1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Hemoglobinopathy Market Size Growth Rate by Type: 2017 VS 2021 VS 2028 1.2.2 Sickle Cell Disease 1.2.3 Alpha Thalassemia 1.2.4 Beta Thalassemia 1.3 Market by Application 1.3.1 Global Hemoglobinopathy Market Share by Application: 2017 VS 2021 VS 2028 1.3.2 Hospitals 1.3.3 Diagnostic Laboratories 1.3.4 Clinics 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Hemoglobinopathy Market Perspective (2017-2028) 2.2 Hemoglobinopathy Growth Trends by Region 2.2.1 Hemoglobinopathy Market Size by Region: 2017 VS 2021 VS 2028 2.2.2 Hemoglobinopathy Historic Market Size by Region (2017-2022) 2.2.3 Hemoglobinopathy Forecasted Market Size by Region (2023-2028) 2.3 Hemoglobinopathy Market Dynamics 2.3.1 Hemoglobinopathy Industry Trends 2.3.2 Hemoglobinopathy Market Drivers 2.3.3 Hemoglobinopathy Market Challenges 2.3.4 Hemoglobinopathy Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Hemoglobinopathy Players by Revenue 3.1.1 Global Top Hemoglobinopathy Players by Revenue (2017-2022) 3.1.2 Global Hemoglobinopathy Revenue Market Share by Players (2017-2022) 3.2 Global Hemoglobinopathy Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Players Covered: Ranking by Hemoglobinopathy Revenue 3.4 Global Hemoglobinopathy Market Concentration Ratio 3.4.1 Global Hemoglobinopathy Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Hemoglobinopathy Revenue in 2021 3.5 Hemoglobinopathy Key Players Head office and Area Served 3.6 Key Players Hemoglobinopathy Product Solution and Service 3.7 Date of Enter into Hemoglobinopathy Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Hemoglobinopathy Breakdown Data by Type 4.1 Global Hemoglobinopathy Historic Market Size by Type (2017-2022) 4.2 Global Hemoglobinopathy Forecasted Market Size by Type (2023-2028) 5 Hemoglobinopathy Breakdown Data by Application 5.1 Global Hemoglobinopathy Historic Market Size by Application (2017-2022) 5.2 Global Hemoglobinopathy Forecasted Market Size by Application (2023-2028) 6 North America 6.1 North America Hemoglobinopathy Market Size (2017-2028) 6.2 North America Hemoglobinopathy Market Size by Country (2017-2022) 6.3 North America Hemoglobinopathy Market Size by Country (2023-2028) 6.4 United States 6.5 Canada 7 Europe 7.1 Europe Hemoglobinopathy Market Size (2017-2028) 7.2 Europe Hemoglobinopathy Market Size by Country (2017-2022) 7.3 Europe Hemoglobinopathy Market Size by Country (2023-2028) 7.4 Germany 7.5 France 7.6 U.K. 7.7 Italy 7.8 Russia 7.9 Nordic Countries 8 Asia-Pacific 8.1 Asia-Pacific Hemoglobinopathy Market Size (2017-2028) 8.2 Asia-Pacific Hemoglobinopathy Market Size by Country (2017-2022) 8.3 Asia-Pacific Hemoglobinopathy Market Size by Country (2023-2028) 8.4 China 8.5 Japan 8.6 South Korea 8.7 Southeast Asia 8.8 India 8.9 Australia 9 Latin America 9.1 Latin America Hemoglobinopathy Market Size (2017-2028) 9.2 Latin America Hemoglobinopathy Market Size by Country (2017-2022) 9.3 Latin America Hemoglobinopathy Market Size by Country (2023-2028) 9.4 Mexico 9.5 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Hemoglobinopathy Market Size (2017-2028) 10.2 Middle East & Africa Hemoglobinopathy Market Size by Country (2017-2022) 10.3 Middle East & Africa Hemoglobinopathy Market Size by Country (2023-2028) 10.4 Turkey 10.5 Saudi Arabia 10.6 UAE 11 Key Players Profiles 11.1 Abbott Diagnostics 11.1.1 Abbott Diagnostics Company Detail 11.1.2 Abbott Diagnostics Business Overview 11.1.3 Abbott Diagnostics Hemoglobinopathy Introduction 11.1.4 Abbott Diagnostics Revenue in Hemoglobinopathy Business (2017-2022) 11.1.5 Abbott Diagnostics Recent Development 11.2 Bio-Rad Laboratories 11.2.1 Bio-Rad Laboratories Company Detail 11.2.2 Bio-Rad Laboratories Business Overview 11.2.3 Bio-Rad Laboratories Hemoglobinopathy Introduction 11.2.4 Bio-Rad Laboratories Revenue in Hemoglobinopathy Business (2017-2022) 11.2.5 Bio-Rad Laboratories Recent Development 11.3 Danaher Corporation 11.3.1 Danaher Corporation Company Detail 11.3.2 Danaher Corporation Business Overview 11.3.3 Danaher Corporation Hemoglobinopathy Introduction 11.3.4 Danaher Corporation Revenue in Hemoglobinopathy Business (2017-2022) 11.3.5 Danaher Corporation Recent Development 11.4 Mindray Medical International 11.4.1 Mindray Medical International Company Detail 11.4.2 Mindray Medical International Business Overview 11.4.3 Mindray Medical International Hemoglobinopathy Introduction 11.4.4 Mindray Medical International Revenue in Hemoglobinopathy Business (2017-2022) 11.4.5 Mindray Medical International Recent Development 11.5 Nexcelom Bioscience 11.5.1 Nexcelom Bioscience Company Detail 11.5.2 Nexcelom Bioscience Business Overview 11.5.3 Nexcelom Bioscience Hemoglobinopathy Introduction 11.5.4 Nexcelom Bioscience Revenue in Hemoglobinopathy Business (2017-2022) 11.5.5 Nexcelom Bioscience Recent Development 11.6 Nihon Kohden 11.6.1 Nihon Kohden Company Detail 11.6.2 Nihon Kohden Business Overview 11.6.3 Nihon Kohden Hemoglobinopathy Introduction 11.6.4 Nihon Kohden Revenue in Hemoglobinopathy Business (2017-2022) 11.6.5 Nihon Kohden Recent Development 11.7 PerkinElmer 11.7.1 PerkinElmer Company Detail 11.7.2 PerkinElmer Business Overview 11.7.3 PerkinElmer Hemoglobinopathy Introduction 11.7.4 PerkinElmer Revenue in Hemoglobinopathy Business (2017-2022) 11.7.5 PerkinElmer Recent Development 11.8 Siemens Healthineers 11.8.1 Siemens Healthineers Company Detail 11.8.2 Siemens Healthineers Business Overview 11.8.3 Siemens Healthineers Hemoglobinopathy Introduction 11.8.4 Siemens Healthineers Revenue in Hemoglobinopathy Business (2017-2022) 11.8.5 Siemens Healthineers Recent Development 11.9 Sysmex Corporation 11.9.1 Sysmex Corporation Company Detail 11.9.2 Sysmex Corporation Business Overview 11.9.3 Sysmex Corporation Hemoglobinopathy Introduction 11.9.4 Sysmex Corporation Revenue in Hemoglobinopathy Business (2017-2022) 11.9.5 Sysmex Corporation Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Hemoglobinopathy Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028 Table 2. Key Players of Sickle Cell Disease Table 3. Key Players of Alpha Thalassemia Table 4. Key Players of Beta Thalassemia Table 5. Global Hemoglobinopathy Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028 Table 6. Global Hemoglobinopathy Market Size by Region (US$ Million): 2017 VS 2021 VS 2028 Table 7. Global Hemoglobinopathy Market Size by Region (2017-2022) & (US$ Million) Table 8. Global Hemoglobinopathy Market Share by Region (2017-2022) Table 9. Global Hemoglobinopathy Forecasted Market Size by Region (2023-2028) & (US$ Million) Table 10. Global Hemoglobinopathy Market Share by Region (2023-2028) Table 11. Hemoglobinopathy Market Trends Table 12. Hemoglobinopathy Market Drivers Table 13. Hemoglobinopathy Market Challenges Table 14. Hemoglobinopathy Market Restraints Table 15. Global Hemoglobinopathy Revenue by Players (2017-2022) & (US$ Million) Table 16. Global Hemoglobinopathy Market Share by Players (2017-2022) Table 17. Global Top Hemoglobinopathy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hemoglobinopathy as of 2021) Table 18. Ranking of Global Top Hemoglobinopathy Companies by Revenue (US$ Million) in 2021 Table 19. Global 5 Largest Players Market Share by Hemoglobinopathy Revenue (CR5 and HHI) & (2017-2022) Table 20. Key Players Headquarters and Area Served Table 21. Key Players Hemoglobinopathy Product Solution and Service Table 22. Date of Enter into Hemoglobinopathy Market Table 23. Mergers & Acquisitions, Expansion Plans Table 24. Global Hemoglobinopathy Market Size by Type (2017-2022) & (US$ Million) Table 25. Global Hemoglobinopathy Revenue Market Share by Type (2017-2022) Table 26. Global Hemoglobinopathy Forecasted Market Size by Type (2023-2028) & (US$ Million) Table 27. Global Hemoglobinopathy Revenue Market Share by Type (2023-2028) Table 28. Global Hemoglobinopathy Market Size by Application (2017-2022) & (US$ Million) Table 29. Global Hemoglobinopathy Revenue Market Share by Application (2017-2022) Table 30. Global Hemoglobinopathy Forecasted Market Size by Application (2023-2028) & (US$ Million) Table 31. Global Hemoglobinopathy Revenue Market Share by Application (2023-2028) Table 32. North America Hemoglobinopathy Market Size by Country (2017-2022) & (US$ Million) Table 33. North America Hemoglobinopathy Market Size by Country (2023-2028) & (US$ Million) Table 34. Europe Hemoglobinopathy Market Size by Country (2017-2022) & (US$ Million) Table 35. Europe Hemoglobinopathy Market Size by Country (2023-2028) & (US$ Million) Table 36. Asia-Pacific Hemoglobinopathy Market Size by Region (2017-2022) & (US$ Million) Table 37. Asia-Pacific Hemoglobinopathy Market Size by Region (2023-2028) & (US$ Million) Table 38. Latin America Hemoglobinopathy Market Size by Country (2017-2022) & (US$ Million) Table 39. Latin America Hemoglobinopathy Market Size by Country (2023-2028) & (US$ Million) Table 40. Middle East & Africa Hemoglobinopathy Market Size by Country (2017-2022) & (US$ Million) Table 41. Middle East & Africa Hemoglobinopathy Market Size by Country (2023-2028) & (US$ Million) Table 42. Abbott Diagnostics Company Detail Table 43. Abbott Diagnostics Business Overview Table 44. Abbott Diagnostics Hemoglobinopathy Product Table 45. Abbott Diagnostics Revenue in Hemoglobinopathy Business (2017-2022) & (US$ Million) Table 46. Abbott Diagnostics Recent Development Table 47. Bio-Rad Laboratories Company Detail Table 48. Bio-Rad Laboratories Business Overview Table 49. Bio-Rad Laboratories Hemoglobinopathy Product Table 50. Bio-Rad Laboratories Revenue in Hemoglobinopathy Business (2017-2022) & (US$ Million) Table 51. Bio-Rad Laboratories Recent Development Table 52. Danaher Corporation Company Detail Table 53. Danaher Corporation Business Overview Table 54. Danaher Corporation Hemoglobinopathy Product Table 55. Danaher Corporation Revenue in Hemoglobinopathy Business (2017-2022) & (US$ Million) Table 56. Danaher Corporation Recent Development Table 57. Mindray Medical International Company Detail Table 58. Mindray Medical International Business Overview Table 59. Mindray Medical International Hemoglobinopathy Product Table 60. Mindray Medical International Revenue in Hemoglobinopathy Business (2017-2022) & (US$ Million) Table 61. Mindray Medical International Recent Development Table 62. Nexcelom Bioscience Company Detail Table 63. Nexcelom Bioscience Business Overview Table 64. Nexcelom Bioscience Hemoglobinopathy Product Table 65. Nexcelom Bioscience Revenue in Hemoglobinopathy Business (2017-2022) & (US$ Million) Table 66. Nexcelom Bioscience Recent Development Table 67. Nihon Kohden Company Detail Table 68. Nihon Kohden Business Overview Table 69. Nihon Kohden Hemoglobinopathy Product Table 70. Nihon Kohden Revenue in Hemoglobinopathy Business (2017-2022) & (US$ Million) Table 71. Nihon Kohden Recent Development Table 72. PerkinElmer Company Detail Table 73. PerkinElmer Business Overview Table 74. PerkinElmer Hemoglobinopathy Product Table 75. PerkinElmer Revenue in Hemoglobinopathy Business (2017-2022) & (US$ Million) Table 76. PerkinElmer Recent Development Table 77. Siemens Healthineers Company Detail Table 78. Siemens Healthineers Business Overview Table 79. Siemens Healthineers Hemoglobinopathy Product Table 80. Siemens Healthineers Revenue in Hemoglobinopathy Business (2017-2022) & (US$ Million) Table 81. Siemens Healthineers Recent Development Table 82. Sysmex Corporation Company Detail Table 83. Sysmex Corporation Business Overview Table 84. Sysmex Corporation Hemoglobinopathy Product Table 85. Sysmex Corporation Revenue in Hemoglobinopathy Business (2017-2022) & (US$ Million) Table 86. Sysmex Corporation Recent Development Table 87. Research Programs/Design for This Report Table 88. Key Data Information from Secondary Sources Table 89. Key Data Information from Primary Sources List of Figures Figure 1. Global Hemoglobinopathy Market Share by Type: 2021 VS 2028 Figure 2. Sickle Cell Disease Features Figure 3. Alpha Thalassemia Features Figure 4. Beta Thalassemia Features Figure 5. Global Hemoglobinopathy Market Share by Application in 2021 & 2028 Figure 6. Hospitals Case Studies Figure 7. Diagnostic Laboratories Case Studies Figure 8. Clinics Case Studies Figure 9. Hemoglobinopathy Report Years Considered Figure 10. Global Hemoglobinopathy Market Size (US$ Million), Year-over-Year: 2017-2028 Figure 11. Global Hemoglobinopathy Market Size, (US$ Million), 2017 VS 2021 VS 2028 Figure 12. Global Hemoglobinopathy Market Share by Region: 2021 VS 2028 Figure 13. Global Hemoglobinopathy Market Share by Players in 2021 Figure 14. Global Top Hemoglobinopathy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hemoglobinopathy as of 2021) Figure 15. The Top 10 and 5 Players Market Share by Hemoglobinopathy Revenue in 2021 Figure 16. North America Hemoglobinopathy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 17. North America Hemoglobinopathy Market Share by Country (2017-2028) Figure 18. United States Hemoglobinopathy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 19. Canada Hemoglobinopathy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 20. Europe Hemoglobinopathy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 21. Europe Hemoglobinopathy Market Share by Country (2017-2028) Figure 22. Germany Hemoglobinopathy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 23. France Hemoglobinopathy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 24. U.K. Hemoglobinopathy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 25. Italy Hemoglobinopathy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 26. Russia Hemoglobinopathy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 27. Nordic Countries Hemoglobinopathy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 28. Asia-Pacific Hemoglobinopathy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 29. Asia-Pacific Hemoglobinopathy Market Share by Region (2017-2028) Figure 30. China Hemoglobinopathy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 31. Japan Hemoglobinopathy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 32. South Korea Hemoglobinopathy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 33. Southeast Asia Hemoglobinopathy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 34. India Hemoglobinopathy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 35. Australia Hemoglobinopathy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 36. Latin America Hemoglobinopathy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 37. Latin America Hemoglobinopathy Market Share by Country (2017-2028) Figure 38. Mexico Hemoglobinopathy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 39. Brazil Hemoglobinopathy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 40. Middle East & Africa Hemoglobinopathy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 41. Middle East & Africa Hemoglobinopathy Market Share by Country (2017-2028) Figure 42. Turkey Hemoglobinopathy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 43. Saudi Arabia Hemoglobinopathy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 44. Abbott Diagnostics Revenue Growth Rate in Hemoglobinopathy Business (2017-2022) Figure 45. Bio-Rad Laboratories Revenue Growth Rate in Hemoglobinopathy Business (2017-2022) Figure 46. Danaher Corporation Revenue Growth Rate in Hemoglobinopathy Business (2017-2022) Figure 47. Mindray Medical International Revenue Growth Rate in Hemoglobinopathy Business (2017-2022) Figure 48. Nexcelom Bioscience Revenue Growth Rate in Hemoglobinopathy Business (2017-2022) Figure 49. Nihon Kohden Revenue Growth Rate in Hemoglobinopathy Business (2017-2022) Figure 50. PerkinElmer Revenue Growth Rate in Hemoglobinopathy Business (2017-2022) Figure 51. Siemens Healthineers Revenue Growth Rate in Hemoglobinopathy Business (2017-2022) Figure 52. Sysmex Corporation Revenue Growth Rate in Hemoglobinopathy Business (2017-2022) Figure 53. Bottom-up and Top-down Approaches for This Report Figure 54. Data Triangulation Figure 55. Key Executives Interviewed

Abbott Diagnostics Bio-Rad Laboratories Danaher Corporation Mindray Medical International Nexcelom Bioscience Nihon Kohden PerkinElmer Siemens Healthineers Sysmex Corporation